Puma Aril Modern Tech Unisex Adults' LowTop Sneakers Black Blackhigh Risk Red 01 4t4HkLG

B00WM4OWYM
Puma Aril Modern Tech, Unisex Adults' Low-Top Sneakers Black (Black-high Risk Red 01)
  • Has removable insert : true
  • Outer Material: Smooth Leather
  • Inner Material: Leather
  • Sole: Gum Rubber
  • Closure: Speed-Laces
  • Heel Type: Flat
  • Shoe Width: Normal
Puma Aril Modern Tech, Unisex Adults' Low-Top Sneakers Black (Black-high Risk Red 01) Puma Aril Modern Tech, Unisex Adults' Low-Top Sneakers Black (Black-high Risk Red 01) Puma Aril Modern Tech, Unisex Adults' Low-Top Sneakers Black (Black-high Risk Red 01) Puma Aril Modern Tech, Unisex Adults' Low-Top Sneakers Black (Black-high Risk Red 01) Puma Aril Modern Tech, Unisex Adults' Low-Top Sneakers Black (Black-high Risk Red 01)
Follow us on web
Newsletter
Calendar
Language
Newsletter
Browse
Pharmaceuticals

Explore Other Industries

Indian pharmaceutical industry supplies over 50 per cent of global demand vaccines.

Latest update: June, 2018

Notes: Source:

Industry

Browse:

Related News

Last Updated: July 03, 2018

Last Updated: June, 2018

Introduction

India is the largest provider of generic drugs globally. Indian pharmaceutical sector industry supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicine in UK.

India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers who have the potential to steer the industry ahead to an even higher level. Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immuno Deficiency Syndrome) are supplied by Indian pharmaceutical firms.

Market Size

The pharmaceutical sector was valued at US$ 33 billion in 2017. The country’s pharmaceutical industry is expected to expand at a CAGR of 22.4 per cent over 2015–20 to reach US$ 55 billion. India’s pharmaceutical exports stood at US$ 17.27 billion in 2017-18 and are expected to reach US$ 20 billion by 2020.

Indian companies received 304 Abbreviated New Drug Application (ANDA) approvals from the US Food and Drug Administration (USFDA) in 2017. The country accounts for around 30 per cent (by volume) and about 10 per cent (value) in the US$ 70-80 billion US generics market.

India's biotechnology industry comprising bio-pharmaceuticals, bio-services, bio-agriculture, bio-industry and bioinformatics is expected grow at an average growth rate of around 30 per cent a year and reach US$ 100 billion by 2025. Biopharma, comprising vaccines, therapeutics and diagnostics, is the largest sub-sector contributing nearly 62 per cent of the total revenues at Rs 12,600 crore (US$ 1.89 billion).

Investments

The Union Cabinet has given its nod for the amendment of the existing Foreign Direct Investment (FDI) policy in the pharmaceutical sector in order to allow FDI up to 100 per cent under the automatic route for manufacturing of medical devices subject to certain conditions.

The drugs and pharmaceuticals sector attracted cumulative FDI inflows worth US$ 15.59 billion between April 2000 and December 2017, according to data released by the Department of Industrial Policy and Promotion (DIPP).

Some of the recent developments/investments in the Indian pharmaceutical sector are as follows:

Government Initiatives

Some of the initiatives taken by the government to promote the pharmaceutical sector in India are as follows:

Road Ahead

Medicine spending in India is expected to increase at 9-12 per cent CAGR between 2018-22 to US$ 26-30 billion, driven by increasing consumer spending, rapid urbanisation, and raising healthcare insurance among others.

Going forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as such as cardiovascular, anti-diabetes, anti-depressants and anti-cancers that are on the rise.

The Indian government has taken many steps to reduce costs and bring down healthcare expenses. Speedy introduction of generic drugs into the market has remained in focus and is expected to benefit the Indian pharmaceutical companies. In addition, the thrust on rural health programmes, lifesaving drugs and preventive vaccines also augurs well for the pharmaceutical companies.

Exchange Rate Used: INR 1 = US$ 0.0155 as on March 30, 2018

Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.

Industry

Browse:

Related News

Last Updated: July 03, 2018

Pharma Clusters
Industry Contacts

WINNING THE WORLD

Indian pharma company have won around 40 per cent of all Abbreviated New Drug Approval (ANDA) from the US Food and Drug Administration (FDA) between j...

+ More >

India Now Magazine

The Luxe Edge - Reshaping India's Lifestyle Choices

Geox J Sandal Sukie Girl Girls vb51VKRaiO

+ More Publications >

Fintech, i.e. the technology that enables banking and financial services, is a very fast growing space in India, especially for the start-up domain. Fintechs are offering...

The Indian technology start-up domain is proudly placed at the fourth largest position in the world. The industry was sized at US$ 35 billion in FY18. Last decade saw eme...

Textiles have been one of the oldest and largest industries in India historically, second only to agriculture, and it generates jobs for millions of people. The current e...

Today is the most opportune time for India to revolutionise its science and technology ecosystem. The size of our economy provides the capital, manpower and market to inv...

Daimler India Commercial Vehicle has been able to create a space for its offerings in the already crowded domestic commercial vehicle market. Erich Nesselhauf, MD C...

TUV Rheinland India is a subsidiary of the TUV Rheinland Group, Germany. As part of the India, Middle East, Africa Asia Pacific Group, it caters to the Indian marke...

Netmed.com (India ki pharmacy), is an online portal for medicines where one can upload the prescription, order medicines, and get them delivered at the doorstep. The company came into being in 2015 and since then it is trying to make all the modern medicines available and affordable for all with a hybrid inventory/marketplace model...

Join IBEF.org now. Enjoy FREE subscriptions downloads, updates and more.

Error

Already a member? Scarpa Mojito Plus GTX charcoal 1aJLBOd
/ Retrieve Password

Copyright © 2010-2018 India Brand Equity Foundation

This website uses cookies

URBANARA.co.uk uses cookies to improve your shopping experience. By continuing to use the site, you consent to our use of cookies.
Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Inactive cookies are cookies that are currently being classified, as well as cookies that have been deactivated, e.g. due to expired or paused marketing campaigns. These cookies are currently not in use.
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
Cookie declaration last updated on 15/06/2018 by Cookiebot
Call us for free 0800 77 97 527 | Tamaris Women’s 25932 Boots Black wFx1z

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Spring Summer '18

Shop by Category

Shop by Collection

Last Chance: Living

Shop by Category

Shop by Collection

Mephisto Women’s Emilie Ballet Flats bleu INDIGO lLUWmz
> Tamaris Women’s 25234 Ankle Boots Brown Black Black 001 6XMVTdb
> Polyester

Company

Nike Mens Hyper Dry Breathe TShirt Volt/Barely Volt/Black 1u29xY
Unique Trust
Press
Partnerships
Legal Disclaimer

Products

Pikolinos Women’s Cadamunt W3kv17 Espadrilles Pink Pink dRLvcsPvo
Artificial Intelligence
Security for Digital identities
Gran Sasso 54226NERO Polo misto cashmere Woman Z04Qbqh9c
Secure Microcontrollers
Bernie Mev Womens Easy Fashion Sneaker Bronze IW2FNSpt
Secure Crypto NFC modules
QuoVadis

Solutions

Coolcept Women Mid Heel Sandals Block Heels Ankle Strap Suede Ladies Dress Heeled Shoes Open Toe ¡­ Purple SsWLL
Bensimon Tennis Blanket Navy Beige YNUYo8H
Secured IoT
VogueZone009 Females Round Closed Toe Microfibre PU Frosted High Heels Solid Pump Shoe with Metalornament Red vwwXlgJ
Wearable Payments
Secure Connected Cars

Investors

Key Figures
Colorful TM New Fashion Womens Snow Boots Winter Boots Warm Ankle Boots Warm Winter Shoes Brown iE9pxGwf
Dearfoams Mens Boater Moccasin SlipOn Loafer Black V0FsEREapy
Shareholders Contacts

WISeKey SA

Route de Pré-Bois 29, P.O. Box 853 CH-1215 Geneva 15, Switzerland Phone: +41 22 594 3000 Fax: +41 22 594 3001 General Information: info@wisekey.com Sales: AgooLar Womens Imitated Suede Assorted Color Pull On Round Closed Toe Low Heels Boots Apricot oPsf95
Technical Support: support@wisekey.com

Social

Copyright © 1999 - 2018 by WISeKey. All Rights Reserved. amaraglobal Womens Boots Weiß LIuDh
| Legal disclaimer | Privacy | Easemax Womens Trendy Round Toe Mid Chunky Heel Slip On Platform Boots Matteblack mABf2m